Skip to main content
. 2019 Dec 16;2:100025. doi: 10.1016/j.bbih.2019.100025

Fig. 3.

Fig. 3

Trends in landmark analysis hazard ratios. The analyses presented in Table 1 were performed at the 1st quartile (202 days), median (395 days), and 3rd quartile (704 days) of follow-up. The boxes show follow-up times for all patients with the subset of the sample used in each of the final analyses colored red and blue, indicating SSRI use up to the landmark time.